Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J. Solomon, Marilyn K. Glassberg, Rie Maurer et al.|The Lancet Respiratory Medicine|2022Cited by 211
Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary FibrosisJonathan A. Rose, Gary M. Hunninghake, Maria A. Planchart Ferretto et al.|American Journal of Respiratory and Critical Care Medicine|2022Cited by 19